(Q79124424)

English

RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?

scientific article published on 01 November 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? (English)

1 reference

10.1016/S0360-3016(03)00640-0

https://api.crossref.org/works/10.1016/S0360-3016(03)00640-0

18 March 2024

1 reference

10.1016/S0360-3016(03)00640-0

https://api.crossref.org/works/10.1016/S0360-3016(03)00640-0

18 March 2024

author name string

Kathryn Winter

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Walter Bosch

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Srinivasan Vijayakumar

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Jeff Michalski

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

James Purdy

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Richard K. Valicenti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529764

18 March 2024

James D. Cox

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529764

18 March 2024

Howard M. Sandler

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529764

18 March 2024

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301603006400?httpAccept=text/xml

1 reference

10.1016/S0360-3016(03)00640-0

https://api.crossref.org/works/10.1016/S0360-3016(03)00640-0

18 March 2024

https://api.elsevier.com/content/article/PII:S0360301603006400?httpAccept=text/plain

1 reference

10.1016/S0360-3016(03)00640-0

https://api.crossref.org/works/10.1016/S0360-3016(03)00640-0

18 March 2024

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

614-620

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of dose on local control of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor control in definitive irradiation of localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of endocrine therapy on the primary lesion in patients with prostate carcinoma as evaluated by endorectal magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900640-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(03)00640-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529764%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79124424&oldid=2104881533"